
|Articles|September 1, 2003
Disparity minimal between races in glaucoma drug response
San Francisco-Should a patient's race play a role in an ophthalmologist's decision as to which glaucoma medications to use? Shan C. Lin, MD, believes evidence to do so is lacking.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
SpyGlass Pharma releases positive data from 2 trials of Bimatoprost Drug Pad-IOL System
2
Beyond the surface: Tackling complex dry eye cases
3
Redefining glaucoma care: Where innovation meets clinical insight
4
An Extreme Case of Demodex Blepharitis: From Misdiagnosis to Remarkable Recovery
5



















































.png)


